Semble is a London-based provider of an integrated clinical system that enables healthcare businesses of all sizes to manage their practice. Its platform is designed to streamline workflows and deliver insights for better patient and business outcomes. The system supports more than 70 specialties and is used by over 10,000 healthcare professionals across the UK and France. The company was founded by Christoph Lippuner and Mikael Landau. Semble recently closed a $15M Series B and intends to use the funds to support ongoing platform growth and expansion in the UK and France.

Total raised

$15M

Funding rounds

1

Latest round

Series B

Latest activity

Oct 2024